Worth reading
48Recurring
Scored from 5 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
26
Year-on-year change in profit before tax (%)Wording
Conditional
How definitive the wording is.Results for this period
Full year1 April 2025–31 March 2026ConsolidatedIFRSNet Sales947,749¥ millionYear on year +9.4%
Ordinary income327,668¥ millionYear on year +26.0%
Net income attributable to owners of the parent253,085¥ millionYear on year +25.2%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
Net income per share¥743.93
Financial position at period-end
Total assets1,300,897¥ million
of which net assets 1,035,004 ¥ millionEquity ratio 78.4%vs. prior year-end -0.5pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+278,446
Investment-7,586
Financials-261,259
Net change+9,601
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥574,092 million
Segment revenueLife Care ¥590,680 million (YoY +7.2%), Information and Communications ¥354,751 million (YoY +14.0%), Other ¥2,318 million (YoY -42.4%)
Segment profitLife Care ¥129,531 million (YoY +43.3%), Information and Communications ¥192,325 million (YoY +12.9%), Other ¥4,321 million (YoY +607.2%)
Regional sales¥193,072 million, ¥137,540 million, ¥113,804 million, ¥93,906 million, ¥65,279 million, ¥344,148 million
Outlook and shareholder returns
Full-year earnings forecast
Net SalesUndecided
Operating profitUndecided
Ordinary incomeUndecided
Net incomeUndecided
Annual Dividend Forecast¥295.00 → Undecided
Payout ratio39.7%
Shareholder Return PolicyThe basic policy is to pay progressive dividends, targeting a payout ratio of 40%.
Factors Behind Changes in Business Performance
Revenue increased as both the Life Care and Information and Communications businesses performed well. Profit increased substantially because the actual consideration paid to acquire the equity interest in the Chinese joint venture for intraocular lenses for cataract treatment was lower than initially estimated, resulting in the difference being recognized as one-time income, among other factors.
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed
Material subsequent eventsAt a meeting of the Board of Directors held on 30 April 2026, the Company resolved to cancel 3,576,300 treasury shares on 15 May 2026. Following the cancellation, the total number of shares issued will be 334,838,020.
Impairment loss¥4,924 million
Depreciation and amortization¥58,218 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for securities analysts and institutional investors)
Issued Shares at Period-End338,414,320 shares
Treasury Shares at Period-End2,925,524 shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥947,749 million (YoY +9.4%) |
| Ordinary income | ¥327,668 million (YoY +26.0%) |
| Profit attributable to owners of the parent | ¥253,085 million (YoY +25.2%) |
| Net income per share | ¥743.93 |
| Equity ratio | End of the current fiscal period 78.4% / End of previous period 78.9% |
| Total assets | ¥1,300,897 million |
| Net assets | ¥1,035,004 million |
| Cash flows from operating activities | ¥278,446 million |
| Cash flows from investing activities | ¥-7,586 million |
| Cash flows from financing activities | ¥-261,259 million |
| Cash and cash equivalents at end of period | ¥574,092 million |
| Full-year earnings forecast | Net Sales Undecided / Operating profit Undecided / Ordinary income Undecided / Net income Undecided |
| Annual Dividend Forecast | ¥295.00 → Undecided |
| Payout ratio | 39.7% |
| Shareholder Return Policy | The basic policy is to pay progressive dividends, targeting a payout ratio of 40%. |
| Segment revenue | Life Care ¥590,680 million (YoY +7.2%), Information and Communications ¥354,751 million (YoY +14.0%), Other ¥2,318 million (YoY -42.4%) |
| Segment profit | Life Care ¥129,531 million (YoY +43.3%), Information and Communications ¥192,325 million (YoY +12.9%), Other ¥4,321 million (YoY +607.2%) |
| Regional sales | ¥193,072 million, ¥137,540 million, ¥113,804 million, ¥93,906 million, ¥65,279 million, ¥344,148 million |
| Depreciation and amortization | ¥58,218 million |
| Impairment loss | ¥4,924 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | At a meeting of the Board of Directors held on 30 April 2026, the Company resolved to cancel 3,576,300 treasury shares on 15 May 2026. Following the cancellation, the total number of shares issued will be 334,838,020. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for securities analysts and institutional investors) |
| Issued Shares at Period-End | 338,414,320 shares |
| Treasury Shares at Period-End | 2,925,524 shares |
| Factors Behind Changes in Business Performance | Revenue increased as both the Life Care and Information and Communications businesses performed well. Profit increased substantially because the actual consideration paid to acquire the equity interest in the Chinese joint venture for intraocular lenses for cataract treatment was lower than initially estimated, resulting in the difference being recognized as one-time income, among other factors. |
Items this document does not state (5)
Operating profitOperating MarginRevision to Earnings ForecastOrders received and order backlogBreakdown of extraordinary income (loss)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased as both the Life Care and Information and Communications businesses performed well. Profit increased substantially because the actual consideration paid to acquire the equity interest in the Chinese joint venture established for intraocular lenses for cataract treatment was lower than initially estimated, resulting in the difference being recognized as one-time income, among other factors.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.